In the future, only adults who cannot or do not want to receive the more effective mRNA vaccines from Biontech/Pfizer or Moderna should receive the vaccine, the FDA said on Thursday. The reason for the change in the emergency approval of the vaccine is the increased risk of severe blood clots.
For the same reason, the FDA had already recommended in December to be treated preferentially with the mRNA vaccines. The J&J vaccine hardly plays a role in the USA anyway: only three percent of all injected corona vaccine doses come from J&J subsidiary Janssen.
Suitable for allergy sufferers
People should continue to receive the vaccine if they are at risk of a severe allergic reaction to the mRNA vaccines. Even though access to the other two vaccines is limited, doctors are still allowed to vaccinate J&J.
In addition, the approval includes people “who have personal concerns regarding receiving an mRNA vaccine” and who would otherwise remain unvaccinated. (SDA)
